Jack Gauldie

39.5k citations
428 papers · 33.6k · 9 hit papers · h-index 97

Impact in

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 73
    • Neonatal Respiratory Health Research 58
    • Pulmonary Hypertension Research and Treatments 20
    • Immunotherapy and Immune Responses 43
    • Immune Response and Inflammation 42

Jack Gauldie

421 papers receiving 32.0k citations

Jack Gauldie's Hit Papers

Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis 2011 · 380 citations
3800+17+35Years since publication50010001.5k2.0k2.5k

Peers

Jack Gauldie
Comparison fields: 5 of 168
  • Immunology 8.7k
  • Immunology and Allergy 1.6k
  • Pulmonary and Respiratory Medicine 8.5k
  • Oncology 4.2k
  • Physiology 3.7k
Replace Thomas A. Wynn with:
Thomas A. Wynn United States
Jörg J. Goronzy United States
Cornelia M. Weyand United States
Jay K. Kolls United States
William P. Arend United States
Steven L. Kunkel United States
Peter A. Ward United States
Volker Brinkmann Germany
Wim A. Buurman Netherlands
Niels Borregaard Denmark
Jack Gauldie relative to Thomas A. Wynn United States Thomas A. Wynn's profile →
Citations per field
00.5×1.5×
Thomas A. Wynn · 1×
Citations per year

Countries citing papers authored by Jack Gauldie

Since Specialization
Citations

This map shows the geographic impact of Jack Gauldie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Gauldie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Gauldie more than expected).

Fields of papers citing papers by Jack Gauldie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Gauldie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Gauldie. The network helps show where Jack Gauldie may publish in the future.

Co-authors

The 25 scholars most cited alongside Jack Gauldie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jack Gauldie Line = papers co-authored together Jack Gauldie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The acute phase response
Hit paper breakdown →
19942561
2
Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.
Hit paper breakdown →
19871502
3
IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.
Hit paper breakdown →
19981249
4
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.
Hit paper breakdown →
1997879
5
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Hit paper breakdown →
2007812
6
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
Hit paper breakdown →
2001652
7 2011418
8
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Hit paper breakdown →
2009413
9
Late cutaneous allergic responses in isolated IgE-dependent reactions
Hit paper breakdown →
1973404
10
Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
Hit paper breakdown →
2011380
11 1987333
12 2000330
13 2010328
14 2004325
15
Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation.
1990308
16 1982267
17 1977260
18 2005259
19 1994257
20 2001242

About Jack Gauldie

Jack Gauldie is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Molecular Biology, Genetics and Oncology, having authored 428 papers that have together received 33.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (73 papers), Virus-based gene therapy research (61 papers), Neonatal Respiratory Health Research (58 papers), Immunotherapy and Immune Responses (43 papers), Immune Response and Inflammation (42 papers), Asthma and respiratory diseases (24 papers), CAR-T cell therapy research (22 papers) and Pulmonary Hypertension Research and Treatments (20 papers). The work is most often cited by research in Immunology (8.7k citations), Immunology and Allergy (1.6k citations), Pulmonary and Respiratory Medicine (8.5k citations), Oncology (4.2k citations) and Physiology (3.7k citations). Jack Gauldie has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Heinz Baumann, Martin Kolb, Manel Jordana, Carl D. Richards, Peter J. Margetts, Patricia J. Sime, Frank L. Graham, Kjetil Ask, Heinz Baumann and Gerard Cox. Their work appears in journals such as The Journal of Immunology, American Journal of Respiratory Cell and Molecular Biology, American Journal of Respiratory and Critical Care Medicine, Journal of Clinical Investigation and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact